Newcastle clinical trial investigates psilocybin as a treatment for resistant depression
Science & Health

Newcastle clinical trial investigates psilocybin as a treatment for resistant depression

8 Jun 2026 · Originally published 8 Jun 2026 8/10 Original headline: Psychedelic drugs have been 'life-changing' for some patients with depression
Dr Mourad Wahba is leading a phase three clinical trial in Newcastle to test the efficacy of synthetic psilocybin for patients with treatment-resistant depression. By exploring new therapeutic options for those who have not responded to traditional methods, the research aims to provide a potential path forward for managing severe mood disorders.
Source: Chronicle Live Tyne And Wear
Read the full story

About the AI positivity score

Report this article

Get your regular dose of good news

Follow the best stories on Bluesky or subscribe with your favourite feed reader.

How AI positivity scores work

Scores out of ten are AI estimates of how uplifting a story is, not a measure of accuracy or importance. Different readers may feel differently. Headlines and summaries are AI-written; follow the source link for the original reporting.

How stories are selected